| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Hopper Jonathan Mark is a Chief Medical Officer at Vericel Corp. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 1,652 | $39.14 | $64,659.28 | -2.4% | -6.1% | - | |
| Sep 2, 2025 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 10,000 | $35.77 | $357,700.00 | -13.1% | +12.2% | - | |
| Jun 2, 2025 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 10,000 | $40.09 | $400,900.00 | -13.1% | -14.5% | - | |
| Mar 3, 2025 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 10,000 | $49.53 | $495,300.00 | -13.1% | -18.3% | -30.5% | |
| Dec 2, 2024 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 10,000 | $58.72 | $587,200.00 | -14.6% | -15.7% | -35.9% | |
| Sep 3, 2024 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 10,000 | $49.83 | $498,300.00 | -14.7% | +19.8% | -31.6% | |
| May 20, 2024 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 10,000 | $49.99 | $499,900.00 | -14.7% | -7.5% | -14.9% | |
| Nov 20, 2023 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 5,000 | $36.40 | $182,000.00 | -8.6% | +35.0% | +52.2% | |
| Mar 1, 2022 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 16,738 | $41.43 | $693,430.96 | -15.0% | -33.2% | -26.2% | |
| Dec 22, 2021 | VCEL Vericel Corp | Chief Medical Officer | Sale+OE | 15,881 | $40.11 | $636,929.75 | -11.5% | -15.8% | -39.7% |